Australia’s health authorities are facing a parliamentary inquiry into the safety and quality of illegal peptides, amid a sharp rise in the importation, supply and advertising of unapproved products.
Telehealth platforms and social media are being identified as major drivers of increased peptide use. The issue has taken on greater urgency following the death of actor Richard Norton, which was linked to peptide use.
Health Minister Mark Butler has asked for an inquiry into the online prescribing of peptides, with particular attention on “one-stop-shop style dispensaries” operating through the internet.
“Peptides are often marketed on social media as wonder-drugs but the reality is that they can pose serious health risks to Australian consumers,” Mr Butler said.
He added: “I am extremely concerned about escalating reports by the TGA of unapproved peptides being prescribed and delivered via telehealth and one-stop-shop style dispensaries.”
Warnings over unregulated peptide products
Sydney GP Sneha Wadhwani said peptides were short-chain amino acids produced when proteins break down. While the body naturally produces hundreds of them, concern has focused on those used in injectable weight-loss medicines.
These drugs work by stimulating or replicating a hormone involved in blood-sugar regulation and weight management. Their effects include increasing insulin production, reducing the release of sugar from the liver, slowing the emptying of the stomach and acting on appetite and the brain’s reward centre.
Social media influencers have promoted peptides as a way to build muscle, speed recovery and improve physical appearance. Dr Wadhwani warned that products bought through an unregulated market could contain substances that had not been properly assessed.
“One of the problems of this unregulated market is that because they may not necessarily be TGA approved, we don’t even know what’s in them,” she said.
In Mr Norton’s case, the actor took twice the dose and suffered a severe anaphylactic reaction. Although other health conditions were also involved, it was described as the first case of its kind in Australia.
The Victorian Health Agency has detected 13 related anaphylactic responses associated with peptide use.
Doctors urge supervision for weight-loss medicines
Dr Wadhwani stressed that approved products were different from unregulated imports and should be taken with medical oversight.
“What is TGA approved, we know is safe here in Australia for our patients to use, but it must be used in combination with surveillance and monitoring by a doctor,” she said.
Wegovy is also evolving as a treatment, with a pill version now available. The medication is not covered by Australia’s Pharmaceutical Benefits Scheme, however, and costs between $250 and $400, potentially encouraging some people to seek cheaper alternatives through illegal imports.
Dr Wadhwani cautioned that weight-loss medicines were not a quick fix and that patients could regain weight after stopping treatment. She said they could nevertheless be “a game-changer” for patients who used them properly as part of care supervised by a GP.